Novel biomarkers in diagnosing cardiac ischemia in the emergency department: A systematic review

Resuscitation

Volumn 83, Issue 6, 2012, Pages 684-691

  Lin, Steve ^a,b,c   Yokoyama, Hiroyuki ^d   Rac, Valeria E ^b,c   Brooks, Steven C ^a,b,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Acute coronary syndrome; Cardiac biomarkers; Cardiac ischemia; Systematic review

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CD40 LIGAND; CHOLINE; COPEPTIN; D DIMER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FATTY ACID BINDING PROTEIN; FIBRINOGEN; GELATINASE B; INTERLEUKIN 6; ISCHEMIA MODIFIED ALBUMIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; PLACENTAL GROWTH FACTOR; PLASMINOGEN ACTIVATOR INHIBITOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A; THROMBIN ANTITHROMBIN COMPLEX; TROPONIN; TROPONIN I; TROPONIN T; TRYPTASE;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; CARDIAC PATIENT; COCHRANE LIBRARY; DIAGNOSTIC ACCURACY; EMBASE; EMERGENCY WARD; HEART MUSCLE ISCHEMIA; HUMAN; MEDLINE; NEUTROPHIL COUNT; PEER REVIEW; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; SYSTEMATIC REVIEW; THORAX PAIN;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; EMERGENCY SERVICE, HOSPITAL; FATTY ACID-BINDING PROTEINS; GLYCOPEPTIDES; HUMANS; MATRIX METALLOPROTEINASE 9; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; SERUM ALBUMIN;

EID: 84862777689     PISSN: 03009572     EISSN: 18731570     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2011.12.015     Document Type: Short Survey

References (81)

1. Owens P.L., Barrett M.L., Gibson T.B., Andrews R.M., Weinick R.M., Mutter R.L. Emergency department care in the United States: a profile of national data sources. Ann Emerg Med 2010, 56:150-165.
2. Pope J.H., Aufderheide T.P., Ruthazer R., et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000, 342:1163-1170.
3. Christenson J., Innes G., McKnight D., et al. Safety and efficiency of emergency department assessment of chest discomfort. CMAJ 2004, 170:1803-1807.
4. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 2007, 50:e1-e157.
5. Thygesen K., Alpert J.S., White H.D., et al. Universal definition of myocardial infarction. Circulation 2007, 116:2634-2653.
6. Hazinski M.F., Nolan J.P., Billi J.E., et al. Part 1: Executive summary: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Circulation 2010, 122:S250-S275.
7. Nolan J.P., Hazinski M.F., Billi J.E., et al. Part 1: Executive summary: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Resuscitation 2010, 81(Suppl 1):e1-e25.
8. O'Connor R.E., Bossaert L., Arntz H.R., et al. Part 9: Acute coronary syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Circulation 2010, 122:S422-S465.
9. Bossaert L., O'Connor R.E., Arntz H.R., et al. Part 9: Acute coronary syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Resuscitation 2010, 81(Suppl 1):e175-e212.
10. Empana J.P., Canoui-Poitrine F., Luc G., et al. Contribution of novel biomarkers to incident stable angina and acute coronary syndrome: the PRIME study. Eur Heart J 2008, 29:1966-1974.
11. Apple F.S., Wu A.H., Mair J., et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005, 51:810-824.
12. Appendix. W222A Borgundvaag. Available from: http://circ.ahajournals.org/content/suppl/2005/11/18/CIRCULATIONAHA.105.170522.DC382.
13. Appendix. W222B Steinhart. Available from: http://circ.ahajournals.org/content/suppl/2005/11/18/CIRCULATIONAHA.105.170522.DC383.
14. Morley P.T., Atkins D.L., Billi J.E., et al. Part 3: Evidence evaluation process: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Resuscitation 2010, 81(Suppl 1):e32-e40.
15. Anwaruddin S., Januzzi J.L., Baggish A.L., Lewandrowski E.L., Lewandrowski K.B. Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol 2005, 123:140-145.
16. Body R. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Bet 2. Heart fatty acid binding protein for rapid diagnosis of acute myocardial infarction in the emergency department. Emerg Med J 2009, 26:519-522.
17. Cameron S.J., Green G.B., White C.N., et al. Assessment of BNP and NT-proBNP in emergency department patients presenting with suspected acute coronary syndromes. Clin Biochem 2006, 39:11-18.
18. Cavus U., Coskun F., Yavuz B., et al. Heart-type, fatty-acid binding protein can be a diagnostic marker in acute coronary syndromes. J Natl Med Assoc 2006, 98:1067-1070.
19. Hamilton A.J., Swales L.A., Neill J., et al. Risk stratification of chest pain patients in the emergency department by a nurse utilizing a point of care protocol. Eur J Emerg Med 2008, 15:9-15.
20. Li C.J., Li J.Q., Liang X.F., et al. Point-of-care test of heart-type fatty acid-binding protein for the diagnosis of early acute myocardial infarction. Acta Pharmacol Sin 2010, 31:307-312.
21. Liao J., Chan C.P., Cheung Y.C., et al. Human heart-type fatty acid-binding protein for on-site diagnosis of early acute myocardial infarction. Int J Cardiol 2009, 133:420-423.
22. Mad P., Domanovits H., Fazelnia C., et al. Human heart-type fatty-acid-binding protein as a point-of-care test in the early diagnosis of acute myocardial infarction. QJM 2007, 100:203-210.
23. Xu Q., Chan C.P., Cao X.Y., et al. Cardiac multi-marker strategy for effective diagnosis of acute myocardial infarction. Clin Chim Acta 2010, 411:1781-1787.
24. Adams J.E., Abendschein D.R., Jaffe A.S. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s?. Circulation 1993, 88:750-763.
25. Mitchell A.M., Brown M.D., Menown I.B., Kline J.A. Novel protein markers of acute coronary syndrome complications in low-risk outpatients: a systematic review of potential use in the emergency department. Clin Chem 2005, 51:2005-2012.
26. Charpentier S., Ducasse J.L., Cournot M., et al. Clinical assessment of ischemia-modified albumin and heart fatty acid-binding protein in the early diagnosis of non-ST-elevation acute coronary syndrome in the emergency department. Acad Emerg Med 2010, 17:27-35.
27. Ilva T., Lund J., Porela P., et al. Early markers of myocardial injury: cTnI is enough. Clin Chim Acta 2009, 400:82-85.
28. Kim Y., Kim H., Kim S.Y., et al. Automated heart-type fatty acid-binding protein assay for the early diagnosis of acute myocardial infarction. Am J Clin Pathol 2010, 134:157-162.
29. Nagahara D., Nakata T., Hashimoto A., et al. Early positive biomarker in relation to myocardial necrosis and impaired fatty acid metabolism in patients presenting with acute chest pain at an emergency room. Circ J 2006, 70:419-425.
30. Valle H.A., Riesgo L.G.C., Bel M.S., Gonzalo F.E., Sanchez M.S., Oliva L.I. Clinical assessment of heart-type fatty acid binding protein in early diagnosis of acute coronary syndrome. Eur J Emerg Med 2008, 15:140-144.
31. Xie P.Y., Li Y.P., Chan C.P., Cheung K.Y., Cautherley G.W., Renneberg R. A one-step immunotest for rapid detection of heart-type fatty acid-binding protein in patients with acute coronary syndromes. J Immunoassay Immunochem 2010, 31:24-32.
32. McCann C.J., Glover B.M., Menown I.B., et al. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur Heart J 2008, 29:2843-2850.
33. Dekker M.S., Mosterd A., van't Hof A.W., Hoes A.W. Novel biochemical markers in suspected acute coronary syndrome: systematic review and critical appraisal. Heart 2010, 96:1001-1010.
34. Haltern G., Peiniger S., Bufe A., Reiss G., Gulker H., Scheffold T. Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction. Am J Cardiol 2010, 105:1-9.
35. Orak M., Ustundag M., Guloglu C., Ozhasenekler A., Alyan O., Kale E. The role of the heart-type fatty acid binding protein in the early diagnosis of acute coronary syndrome and its comparison with troponin I and creatine kinase-MB isoform. Am J Emerg Med 2010, 28:891-896.
36. Wu A.H., Morris D.L., Fletcher D.R., Apple F.S., Christenson R.H., Painter P.C. Analysis of the albumin cobalt binding (ACB) test as an adjunct to cardiac troponin I for the early detection of acute myocardial infarction. Cardiovasc Toxicol 2001, 1:147-151.
37. Hwang H.J., Ko Y.G., Kim J.S., et al. Ischemia-modified albumin: is it a reliable diagnostic and prognostic marker for myocardial ischemia in real clinical practice?. Cardiology 2010, 116:123-129.
38. Liyan C., Jie Z., Yonghua W., Xiaozhou H. Assay of ischemia-modified albumin and C-reactive protein for early diagnosis of acute coronary syndromes. J Clin Lab Anal 2008, 22:45-49.
39. Talwalkar S.S., Bon Homme M., Miller J.J., Elin R.J. Ischemia modified albumin, a marker of acute ischemic events: a pilot study. Ann Clin Lab Sci 2008, 38:132-137.
40. Hjortshoj S., Kristensen S.R., Ravkilde J. Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome. Am J Emerg Med 2010, 28:170-176.
41. Lin R.M., Fatovich D.M., Grasko J.M., Vasikaran S.D. Ischaemia modified albumin cannot be used for rapid exclusion of acute coronary syndrome. Emerg Med J 2010, 27:668-671.
42. Roy D., Quiles J., Aldama G., et al. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 2004, 97:297-301.
43. Abadie J.M., Blassingame C.L., Bankson D.D. Albumin cobalt binding assay to rule out acute coronary syndrome. Ann Clin Lab Sci 2005, 35:66-72.
44. Collinson P.O., Gaze D.C., Bainbridge K., et al. Utility of admission cardiac troponin and "Ischemia Modified Albumin" measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emerg Med J 2006, 23:256-261.
45. Keating L., Benger J.R., Beetham R., et al. The PRIMA study: presentation ischaemia-modified albumin in the emergency department. Emerg Med J 2006, 23:764-768.
46. Peacock F., Morris D.L., Anwaruddin S., et al. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 2006, 152:253-262.
47. Sinha M.K., Roy D., Gaze D.C., Collinson P.O., Kaski J.C. Role of "Ischemia modified albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 2004, 21:29-34.
48. Morita E., Yasue H., Yoshimura M., et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993, 88:82-91.
49. Hama N., Itoh H., Shirakami G., et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 1995, 92:1558-1564.
50. Bassan R., Potsch A., Maisel A., et al. B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. Eur Heart J 2005, 26:234-240.
51. Kavsak P.A., Ko D.T., Newman A.M., et al. Upstream markers" provide for early identification of patients at high risk for myocardial necrosis and adverse outcomes. Clin Chim Acta 2008, 387:133-138.
52. Kwan G., Isakson S.R., Beede J., Clopton P., Maisel A.S., Fitzgerald R.L. Short-term serial sampling of natriuretic peptides in patients presenting with chest pain. J Am Coll Cardiol 2007, 49:1186-1192.
53. Mitchell A.M., Garvey J.L., Kline J.A. Multimarker panel to rule out acute coronary syndromes in low-risk patients. Acad Emerg Med 2006, 13:803-806.
54. Nikolaou N.I., Kyriakides Z.S., Tsaglis E.P., Antonatos D.G., Kartsagoulis E.C., Tsigas D.L. Early brain natriuretic peptide increase reflects acute myocardial ischemia in patients with ongoing chest pain. Int J Cardiol 2005, 101:223-229.
55. Apple F.S., Smith S.W., Pearce L.A., Murakami M.M. Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2009, 55:93-100.
56. Brown A.M., Sease K.L., Robey J.L., Shofer F.S., Hollander J.E. The impact of B-type natriuretic peptide in addition to troponin I, creatine kinase-MB, and myoglobin on the risk stratification of emergency department chest pain patients with potential acute coronary syndrome. Ann Emerg Med 2007, 49:153-163.
57. Morgenthaler N.G., Struck J., Alonso C., Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006, 52:112-119.
58. Reichlin T., Hochholzer W., Stelzig C., et al. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009, 54:60-68.
59. Keller T., Tzikas S., Zeller T., et al. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 2010, 55:2096-2106.
60. Bhiladvala P., Strandberg K., Stenflo J., Holm J. Early identification of acute myocardial infarction by activated protein C-protein C inhibitor complex. Thromb Res 2006, 118:213-219.
61. Roy D., Quiles J., Avanzas P., Arroyo-Espliguero R., Sinha M., Kaski J.C. A comparative study of markers of inflammation for the assessment of cardiovascular risk in patients presenting to the emergency department with acute chest pain suggestive of acute coronary syndrome. Int J Cardiol 2006, 109:317-321.
62. Ferroni P., Rosa A., Di Franco M., et al. Prognostic significance of interleukin-6 measurement in the diagnosis of acute myocardial infarction in emergency department. Clin Chim Acta 2007, 381:151-156.
63. Potsch A.A., Siqueira Filho A.G., Tura B.R., et al. C-reactive protein diagnostic and prognostic value in patients presenting at the emergency room with chest pain. Arq Bras Cardiol 2006, 87:275-280.
64. Plaikner M., Peer A., Falkensammer G., et al. Lack of association of soluble CD40 ligand with the presence of acute myocardial infarction or ischemic stroke in the emergency department. Clin Chem 2009, 55:175-178.
65. Body R., Griffith C.A., Keevil B., et al. Choline for diagnosis and prognostication of acute coronary syndromes in the emergency department. Clin Chim Acta 2009, 404:89-94.
66. Lippi G., Filippozzi L., Montagnana M., Salvagno G.L., Guidi G.C. Diagnostic value of D-dimer measurement in patients referred to the emergency department with suspected myocardial ischemia. J Thromb Thrombolysis 2008, 25:247-250.
67. Lippi G., Filippozzi L., Salvagno G.L., et al. Increased mean platelet volume in patients with acute coronary syndromes. Arch Pathol Lab Med 2009, 133:1441-1443.
68. Eggers K.M., Dellborg M., Johnston N., et al. Myeloperoxidase is not useful for the early assessment of patients with chest pain. Clin Biochem 2010, 43:240-245.
69. Basili S., Di Francoi M., Rosa A., et al. Absolute neutrophil counts and fibrinogen levels as an aid in the early diagnosis of acute myocardial infarction. Acta Cardiol 2004, 59:135-140.
70. Bar-Or D., Thomas G.W., Bar-Or R., Rael L., Winkler J.V. Diagnostic potential of phosphorylated cardiac troponin I as a sensitive, cardiac-specific marker for early acute coronary syndrome: preliminary report. Clin Chim Acta 2005, 362:65-70.
71. Moons A.H.M., van der Zee P.M., Bholasingh R., et al. The value of haemostatic markers in the triage of patients with chest pain presenting with a normal or non-diagnostic ECG. Heart 2005, 91:1215-1216.
72. Bigalke B., Haap M., Stellos K., et al. Platelet glycoprotein VI (GPVI) for early identification of acute coronary syndrome in patients with chest pain. Thromb Res 2010, 125:e184-e189.
73. Body R., Ferguson C. Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. Pregnancy-associated plasma protein A: a novel cardiac marker with promise. Emerg Med J 2006, 23:875-877.
74. Elesber A.A., Lerman A., Denktas A.E., et al. Pregnancy associated plasma protein-A and risk stratification of patients presenting with chest pain in the emergency department. Int J Cardiol 2007, 117:365-369.
75. Lippi G., Filippozzi L., Montagnana M., et al. Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute coronary syndromes. Clin Chem Lab Med 2009, 47:353-357.
76. Brown A.M., Wu A.H.B., Clopton P., Robey J.L., Hollander J.E. ST2 in emergency department chest pain patients with potential acute coronary syndromes. Ann Emerg Med 2007, 50:153-158.
77. Kervinen H., Kaartinen M., Makynen H., Palosuo T., Manttari M., Kovanen P.T. Serum tryptase levels in acute coronary syndromes. Int J Cardiol 2005, 104:138-143.
78. International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Part 5: Acute coronary syndromes. Resuscitation 2005;67:249-69.
79. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm.
80. West S, King V, Carey TS, et al. Systems to rate the strength of scientific evidence. Evidence Report/Technology Assessment No. 47 (Prepared by the Research Triangle Institute-University of North Carolina Evidence-based Practice Center under Contract No. 290-97-0011). AHRQ Publication No. 02-E016. Rockville, MD: Agency for Healthcare Research and Quality. April 2002.
81. Shuster M., Billi J.E., Bossaert L., et al. Part 4: Conflict of interest management before, during, and after the 2010 International Consensus Conference on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Resuscitation 2010, 81(Suppl 1):e41-e47.